Literature DB >> 17095088

Pre-assembly of STAT4 with the human IFN-alpha/beta receptor-2 subunit is mediated by the STAT4 N-domain.

Douglas R Tyler1, Meredith E Persky, Loderick A Matthews, Sheuwen Chan, J David Farrar.   

Abstract

CD4(+) T cells regulate adaptive responses to pathogens by secreting unique subsets of cytokines that mediate inflammatory processes. The innate cytokines IL-12 and IFN-alpha/beta regulate type I responses and promote acute IFN-gamma secretion through the activation of the STAT4 transcription factor. Although IL-12-induced STAT4 activation is a conserved pathway across species, IFN-alpha/beta-dependent STAT4 phosphorylation does not occur as efficiently in mice as it does in human T cells. In order to understand this species-specific pathway for IFN-alpha/beta-dependent STAT4 activation, we have examined the molecular basis of STAT4 recruitment by the human IFNAR. In this report, we demonstrate that the N-domain of STAT4 interacts with the cytoplasmic domain of the human, but not the murine IFNAR2 subunit. This interaction mapped to a membrane-proximal segment of the hIFNAR2 spanning amino acids 299-333. Deletion of this region within the hIFNAR2 completely abolishes IFN-alpha/beta-dependent STAT4 tyrosine phosphorylation when expressed in human IFNAR2-deficient fibroblasts. Thus, the human IFNAR2 cytoplasmic domain serves to link STAT4 to the IFNAR as a pre-assembled complex that facilitates cytokine-driven STAT4 activation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17095088      PMCID: PMC2700023          DOI: 10.1016/j.molimm.2006.10.006

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  39 in total

Review 1.  Type I interferons and the Th1/Th2 paradigm.

Authors:  F Sinigaglia; D D'Ambrosio; L Rogge
Journal:  Dev Comp Immunol       Date:  1999 Oct-Dec       Impact factor: 3.636

2.  Recruitment of Stat4 to the human interferon-alpha/beta receptor requires activated Stat2.

Authors:  J D Farrar; J D Smith; T L Murphy; K M Murphy
Journal:  J Biol Chem       Date:  2000-01-28       Impact factor: 5.157

Review 3.  Type I interferons and T helper development.

Authors:  J D Farrar; K M Murphy
Journal:  Immunol Today       Date:  2000-10

4.  IFN-alpha and IL-18 synergistically enhance IFN-gamma production in human NK cells: differential regulation of Stat4 activation and IFN-gamma gene expression by IFN-alpha and IL-12.

Authors:  S Matikainen; A Paananen; M Miettinen; M Kurimoto; T Timonen; I Julkunen; T Sareneva
Journal:  Eur J Immunol       Date:  2001-07       Impact factor: 5.532

5.  IL-12, but not IFN-alpha, promotes STAT4 activation and Th1 development in murine CD4+ T cells expressing a chimeric murine/human Stat2 gene.

Authors:  Meredith E Persky; Kenneth M Murphy; J David Farrar
Journal:  J Immunol       Date:  2005-01-01       Impact factor: 5.422

6.  Role of the Stat4 N domain in receptor proximal tyrosine phosphorylation.

Authors:  T L Murphy; E D Geissal; J D Farrar; K M Murphy
Journal:  Mol Cell Biol       Date:  2000-10       Impact factor: 4.272

7.  IFN-alpha and IL-12 induce IL-18 receptor gene expression in human NK and T cells.

Authors:  T Sareneva; I Julkunen; S Matikainen
Journal:  J Immunol       Date:  2000-08-15       Impact factor: 5.422

8.  Selective loss of type I interferon-induced STAT4 activation caused by a minisatellite insertion in mouse Stat2.

Authors:  J D Farrar; J D Smith; T L Murphy; S Leung; G R Stark; K M Murphy
Journal:  Nat Immunol       Date:  2000-07       Impact factor: 25.606

9.  Stat protein transactivation domains recruit p300/CBP through widely divergent sequences.

Authors:  M Paulson; S Pisharody; L Pan; S Guadagno; A L Mui; D E Levy
Journal:  J Biol Chem       Date:  1999-09-03       Impact factor: 5.157

10.  Murine Stat2 is uncharacteristically divergent.

Authors:  C Park; M J Lecomte; C Schindler
Journal:  Nucleic Acids Res       Date:  1999-11-01       Impact factor: 16.971

View more
  16 in total

1.  Rapamycin generates anti-apoptotic human Th1/Tc1 cells via autophagy for induction of xenogeneic GVHD.

Authors:  Shoba Amarnath; Francis A Flomerfelt; Carliann M Costanzo; Jason E Foley; Jacopo Mariotti; Daniel M Konecki; Anu Gangopadhyay; Michael Eckhaus; Susan Wong; Bruce L Levine; Carl H June; Daniel H Fowler
Journal:  Autophagy       Date:  2010-05-16       Impact factor: 16.016

Review 2.  Genetic regulation of serum cytokines in systemic lupus erythematosus.

Authors:  Silvia N Kariuki; Timothy B Niewold
Journal:  Transl Res       Date:  2009-09-25       Impact factor: 7.012

3.  Blockade of virus infection by human CD4+ T cells via a cytokine relay network.

Authors:  Ann M Davis; Kristan A Hagan; Loderick A Matthews; Gagan Bajwa; Michelle A Gill; Michael Gale; J David Farrar
Journal:  J Immunol       Date:  2008-05-15       Impact factor: 5.422

4.  IFN-alpha is not sufficient to drive Th1 development due to lack of stable T-bet expression.

Authors:  Hilario J Ramos; Ann M Davis; Thaddeus C George; J David Farrar
Journal:  J Immunol       Date:  2007-09-15       Impact factor: 5.422

Review 5.  Regulation of effector and memory T-cell functions by type I interferon.

Authors:  Jonathan P Huber; J David Farrar
Journal:  Immunology       Date:  2011-02-14       Impact factor: 7.397

Review 6.  The molecular basis for differential type I interferon signaling.

Authors:  Gideon Schreiber
Journal:  J Biol Chem       Date:  2017-03-13       Impact factor: 5.157

7.  Genetics of the type I interferon pathway in systemic lupus erythematosus.

Authors:  Yogita Ghodke-Puranik; Timothy B Niewold
Journal:  Int J Clin Rheumtol       Date:  2013-12-01

8.  Targeting STAT4 in systemic sclerosis: a promising new direction.

Authors:  Jammie Barnes; Sandeep K Agarwal
Journal:  Expert Rev Clin Immunol       Date:  2011-07       Impact factor: 4.473

9.  Cutting edge: autoimmune disease risk variant of STAT4 confers increased sensitivity to IFN-alpha in lupus patients in vivo.

Authors:  Silvia N Kariuki; Kyriakos A Kirou; Emma J MacDermott; Lilliana Barillas-Arias; Mary K Crow; Timothy B Niewold
Journal:  J Immunol       Date:  2009-01-01       Impact factor: 5.422

Review 10.  The type I interferons: Basic concepts and clinical relevance in immune-mediated inflammatory diseases.

Authors:  Consuelo M López de Padilla; Timothy B Niewold
Journal:  Gene       Date:  2015-09-26       Impact factor: 3.688

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.